Abstract
Infantile hemangiomas are the most common benign soft tissue tumor of infancy and childhood. Although most infantile hemangiomas are small, innocuous, self-resolving, and require no treatment, a high-risk infantile hemangioma can pose a problem thus systemic treatment should be considered to prevent more serious complications. Oral propranolol is a systemic drug of choice in high risk infantile hemangiomas because of its good efficacy and availability. Here we present a 2-month-old girl with infantile hemangioma that treated with oral propranolol for 6 months and showed good progression of the therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bota M, Popa G, Blag C, Tataru A. Infantile hemangioma: a brief review. Clujul Med. 2015;88:23–7. https://doi.org/10.15386/cjmed-381.
Oiso N, Kimura M, Kawara S, Kawada A. Clinical, dermoscopic, and histopathologic features in a case of infantile hemangioma without proliferation. Pediatr Dermatol. 2011;28:66–8. https://doi.org/10.1111/j.1525-1470.2010.01363.x.
Oiso N, Kawada A. The dermoscopic features in infantile hemangioma. Pediatr Dermatol. 2011;28:591–3. https://doi.org/10.1111/j.1525-1470.2011.01385.x.
Léauté-Labrèze C, de la Roque ED, Hubiche T, Boralevi F, Thambo J-B, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–51. https://doi.org/10.1056/nejmc0708819.
Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol. 2010;74:338–42. https://doi.org/10.1016/j.ijporl.2010.01.001.
Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610–4. https://doi.org/10.1111/j.1525-1470.2009.00975.x.
Sans V, De La Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124 https://doi.org/10.1542/peds.2008-3458.
McGee P, Miller S, Black C, Hoey S. Propranolol for infantile haemangioma: a review of current dosing regime in a regional paediatric hospital. Ulster Med J. 2013;82:16–20.
Szychta P, Stewart K, Anderson W. Treatment of infantile hemangiomas with propranolol: clinical guidelines. Plast Reconstr Surg. 2014; https://doi.org/10.1097/PRS.0000000000000007.
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128–40. https://doi.org/10.1542/peds.2012-1691.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nugroho, W.T., Widia, Y., Citrashanty, I., Sawitri, Zulkarnain, I., Damayanti (2022). Oral Propranolol Treatment for Infantile Hemangioma: A Case Report. In: Arcangeli, F., Lotti, T.M. (eds) Clinical Cases in Neonatal and Infant Dermatology. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-91523-0_31
Download citation
DOI: https://doi.org/10.1007/978-3-030-91523-0_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91522-3
Online ISBN: 978-3-030-91523-0
eBook Packages: MedicineMedicine (R0)